EP3129027A4 - Modulatoren von caspase-6 - Google Patents
Modulatoren von caspase-6 Download PDFInfo
- Publication number
- EP3129027A4 EP3129027A4 EP15829650.9A EP15829650A EP3129027A4 EP 3129027 A4 EP3129027 A4 EP 3129027A4 EP 15829650 A EP15829650 A EP 15829650A EP 3129027 A4 EP3129027 A4 EP 3129027A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- caspase
- modulators
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/28—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having nitrogen atoms of imino groups acylated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461939922P | 2014-02-14 | 2014-02-14 | |
US201462033401P | 2014-08-05 | 2014-08-05 | |
PCT/IB2015/000144 WO2016020732A1 (en) | 2014-08-05 | 2015-02-14 | Modulators of caspase-6 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3129027A1 EP3129027A1 (de) | 2017-02-15 |
EP3129027A4 true EP3129027A4 (de) | 2017-06-21 |
Family
ID=55263221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15829650.9A Withdrawn EP3129027A4 (de) | 2014-02-14 | 2015-02-14 | Modulatoren von caspase-6 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3129027A4 (de) |
JP (1) | JP2018522812A (de) |
AU (1) | AU2015298491A1 (de) |
CA (1) | CA2939655A1 (de) |
DE (1) | DE112015001269T5 (de) |
WO (1) | WO2016020732A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2977947A1 (en) | 2015-03-06 | 2016-09-15 | Pharmakea, Inc. | Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof |
ES2872553T3 (es) | 2015-03-06 | 2021-11-02 | Pharmakea Inc | Inhibidores de lisil oxidasa tipo-2 y usos de los mismos |
CA3013917A1 (en) | 2016-02-09 | 2017-08-17 | Pharmakea, Inc. | Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof |
EP4052707A1 (de) | 2016-09-07 | 2022-09-07 | Pharmakea, Inc. | Verwendung eines lysyloxidase-ähnlichen 2-inhibitors |
BR112019004517A2 (pt) | 2016-09-07 | 2019-08-13 | Pharmakea Inc | formas cristalinas de um inibidor lisil-oxidase-semelhante 2 e métodos de preparação |
KR20220159346A (ko) * | 2019-11-22 | 2022-12-02 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 카스파제 6 억제제 및 이의 용도 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010017408A1 (en) * | 2008-08-06 | 2010-02-11 | The Buck Institute For Age Research | Caspase inhibitors and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0818439B1 (de) * | 1996-07-02 | 1999-10-13 | Nisshin Flour Milling Co., Ltd. | Imid derivate |
JP5342450B2 (ja) * | 2006-12-15 | 2013-11-13 | ブリストル−マイヤーズ スクイブ カンパニー | 第XIa因子インヒビターとしてのアリールプロピオンアミド、アリールアクリルアミド、アリールプロピンアミド、またはアリールメチルウレアアナログ |
-
2015
- 2015-02-14 CA CA2939655A patent/CA2939655A1/en not_active Abandoned
- 2015-02-14 EP EP15829650.9A patent/EP3129027A4/de not_active Withdrawn
- 2015-02-14 DE DE112015001269.9T patent/DE112015001269T5/de not_active Withdrawn
- 2015-02-14 JP JP2016552512A patent/JP2018522812A/ja active Pending
- 2015-02-14 AU AU2015298491A patent/AU2015298491A1/en not_active Abandoned
- 2015-02-14 WO PCT/IB2015/000144 patent/WO2016020732A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010017408A1 (en) * | 2008-08-06 | 2010-02-11 | The Buck Institute For Age Research | Caspase inhibitors and uses thereof |
Non-Patent Citations (4)
Title |
---|
DIETER HUBMANN ET AL: "N-(3-Phenyl-2-propynoyl)benzamide", MOLECULES, 1 January 1999 (1999-01-01), pages M107, XP055372338, Retrieved from the Internet <URL:http://www.mdpi.org/molbank/m0107.htm> [retrieved on 20170512] * |
NILOUFAR ANSARI ET AL: "Attenuation of LPS-induced apoptosis in NGF-differentiated PC12 cells via NF-B pathway and regulation of cellular redox status by an oxazine derivative", BIOCHIMIE, MASSON, PARIS, FR, vol. 93, no. 5, 20 November 2011 (2011-11-20), pages 899 - 908, XP028192107, ISSN: 0300-9084, [retrieved on 20110202], DOI: 10.1016/J.BIOCHI.2011.01.012 * |
OLGA PETINA ET AL: "Preparation of Arylpropynamides and Their Reaction with Malonyl Acid Derivatives", SYNTHESIS, vol. 45, no. 06, 15 February 2013 (2013-02-15), STUTTGART, DE., pages 803 - 809, XP055372325, ISSN: 0039-7881, DOI: 10.1055/s-0032-1316851 * |
RONA K GRAHAM ET AL: "Caspase-6 and neurodegeneration", TRENDS IN NEUROSCIENCE, vol. 34, no. 12, December 2011 (2011-12-01), pages 646 - 656, XP028119167, ISSN: 0166-2236, [retrieved on 20110917], DOI: 10.1016/J.TINS.2011.09.001 * |
Also Published As
Publication number | Publication date |
---|---|
EP3129027A1 (de) | 2017-02-15 |
JP2018522812A (ja) | 2018-08-16 |
CA2939655A1 (en) | 2016-02-11 |
DE112015001269T5 (de) | 2017-06-08 |
WO2016020732A1 (en) | 2016-02-11 |
AU2015298491A1 (en) | 2016-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL283582A (en) | ror - gamma modulators | |
HK1256599A1 (zh) | ROR-γ的調節劑 | |
EP3195630A4 (de) | Geolokalisierungsbasierte piktografen | |
EP3183346A4 (de) | Kanalmodulator | |
EP3140722A4 (de) | Charakterisierung der zustände einer person | |
EP3122721A4 (de) | Ror-gamma-modulatoren und verwendungen davon | |
EP3154561A4 (de) | Modulation der komplementaktivität | |
EP3139943A4 (de) | Kombinationen aus nmdar-modulierenden verbindungen | |
EP3148543A4 (de) | Modulatoren der transkription kleiner moleküle von bromodomänen | |
EP2897004B8 (de) | Uhr | |
EP3364958A4 (de) | Modulatoren der sestrin-gator2-interaktion und verwendungen davon | |
EP3132789A4 (de) | Kosmetikum | |
EP3184498A4 (de) | Abstandshalter | |
EP3092228A4 (de) | Trpa1-modulatoren | |
EP3250230A4 (de) | Modulatoren der komplementaktivität | |
EP3216525A4 (de) | Airbrush-pistole | |
EP3221167A4 (de) | Elektrooptische anordnung | |
EP3128378A4 (de) | Uhr | |
EP3129027A4 (de) | Modulatoren von caspase-6 | |
EP3235501A4 (de) | Verwendung von derivaten von clostridium ghonii | |
EP3384921A4 (de) | Neue verwendung von thiopeptin | |
EP3124013A4 (de) | Kosmetikum | |
EP3209630A4 (de) | Selektive partielle hydrierung von beta-farnesen | |
EP3156039A4 (de) | Spezifische modulatoren der connexin-hemikanäle | |
EP3214112A4 (de) | Element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20160818 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170523 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/535 20060101AFI20170517BHEP Ipc: A61P 25/14 20060101ALI20170517BHEP Ipc: C07D 265/06 20060101ALI20170517BHEP Ipc: A61K 31/165 20060101ALI20170517BHEP Ipc: C07C 251/28 20060101ALI20170517BHEP Ipc: A61P 25/28 20060101ALI20170517BHEP |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GEFFKEN, DETLEF Inventor name: KHANKISCHPUR, MEDHI, MIKE Inventor name: HAYDEN, MICHAEL Inventor name: ERNHOEFER, DAGMAR Inventor name: PETINA, OLGA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07C 251/28 20060101ALI20180122BHEP Ipc: A61P 25/28 20060101ALI20180122BHEP Ipc: A61P 25/14 20060101ALI20180122BHEP Ipc: A61K 31/165 20060101ALI20180122BHEP Ipc: A61K 45/06 20060101ALI20180122BHEP Ipc: C07D 265/06 20060101ALI20180122BHEP Ipc: A61K 31/535 20060101AFI20180122BHEP |
|
18W | Application withdrawn |
Effective date: 20180209 |